Cutaneous macular amyloidosis associated with multiple endocrine neoplasia 2A

Clinical and Experimental Dermatology

Volumn 21, Issue 4, 1996, Pages 313-314

  De Argila, D ^a   Ortiz Romero, P L ^a   Ortiz Frutos, J ^a   Rodriguez Peralto, J L ^a   Iglesias, L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CORTICOSTEROID; RETINOIC ACID;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SIPPLE SYNDROME; TOPICAL DRUG ADMINISTRATION;

AMYLOIDOSIS; FEMALE; HUMANS; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; SKIN DISEASES;

EID: 0029799183     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1996.tb00106.x     Document Type: Article

References (15)

1. Kouseff BG. Multiple endocrine neoplasia 2 (MEN 2)/MEN 2A (Sipple syndrome). Dermatol Clinics 1995; 13: 91-7.
2. Mathew CGP, Chin KS, Easton DF et al. A linked genetic marker for multiple endocrine neoplasia type 2A chromosome 10. Nature 1987; 328: 527-8.
3. Ceccherini I, Romei C, Barone V et al. Identification of the Cys634-Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis. J Endocrinol Invest 1994; 17: 201-4.
4. Nunziata V, Di Giovani G, Lettera AM et al. Cutaneous lichen amyloidosis associated with multiple endocrine neoplasia type 2A. Henry Ford Hosp Med J 1989; 37: 144-6.
5. Gagel RF, Levy ML, Donovan DT et al. Multiple endocrine neoplasia type 2A associated with cutaneous lichen amyloidosis. Ann Intern Med 1989; 111: 802-6.
6. Kousseff BG, Espinoza C, Zamore GA. Sipple syndrome with lichen amyloidosis as a paracrinopathy: pleiotropy, heterogeneity, or a contiguous gene? J Am Acad Dermatol 1991; 25: 651-7.
7. Robinson MF, Furst EJ, Nunziata V et al. Characterization of the clinical features of five families with hereditary primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2A. Henry Ford Hosp Med J 1992; 40: 249-52.
8. Pacini F, Fugazzola L, Bevilacqua G et al. Multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis: description of a new family. Endocrinol Invest 1993; 16: 295-6.
9. Kousseff BG. Sipple syndrome with lichen amyloidosis as a paracrinopathy. Am J Med Genet 1992; 42: 751-3.
10. Chabre O, Labat F, Pinel N et al. Cutaneous lesion associated with multiple endocrine neoplasia type 2A: lichen amyloidosis or notalgia paresthetica? Henry Ford Hosp Med J 1992; 40: 245-8.
11. Bernhard JD. Macular amyloidosis, notalgia paresthetica and pruritus: three sides of the same coin. Dermatologica 1991; 183: 53-6.
12. Ortiz-Romero PL, Ballestin-Carcavilla C, Lopez-Estebaranz JL et al. Clinicopathologic and immunohistochemical studies on lichen amyloidosis and macular amyloidosis. Arch Dermatol 1994; 130: 1559-60.
13. Chabre O, Labat-Moleur F, Berthod F et al. Atteinte cutanée associée à la néoplasie endocrinienne multiple de type 2A (Syndrome de Sipple). Un marqueur clinique précoce. Presse Méd 1992; 21: 299-303.
14. Bugalho MJ, Limbert E, Sobrinho LG et al. A kindred with multiple endocrine neoplasia type 2A associated with pruritic skin lesions. Cancer 1992; 70: 2664-7.
15. Wallengren J. Treatment of notalgia paresthetica with topical capsaicin. J Am Acad Dermatol 1991; 24: 286-8.